6825-71-4

Basic information

• Product Name: ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate
• Synonyms: ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate;3,5-Diamino-4-ethoxycarbonylpyrazole;Ethyl 3,5-diamino-4-pyrazolecarboxylate;1H-Pyrazole-4-carboxylic acid, 3,5-diamino-, ethyl ester;3,5-Diamino-1H-pyrazole-4-carboxylic acid ethyl ester;EOS-61556
• CAS NO: 6825-71-4
• Molecular Formula: C₆H₁₀N₄O₂
• Molecular Weight: 170
• Mol File: 6825-71-4.mol
• Article Data: 11

Chemical Properties

• Melting Point: 189-190℃
• Boiling Point: 419.4±40.0 °C(Predicted)
• Appearance: /
• Density: 1.418±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 14.26±0.50(Predicted)
• CAS DataBase Reference: ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate(6825-71-4)
• EPA Substance Registry System: ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate(6825-71-4)

Safety Data

• Hazardous Substances Data: 6825-71-4(Hazardous Substances Data)

Usage

Description

Ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate is a carboxylic acid ester derivative, a type of organic compound that features a carboxylate group attached to a pyrazole ring. ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate is known for its potential applications in the pharmaceutical industry due to its unique chemical structure and properties.

Uses

Used in Pharmaceutical Industry:
Ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate is used as a pharmaceutical intermediate for the synthesis of various drug compounds. Its unique structure allows it to serve as a building block in the development of new medications, potentially leading to the creation of novel therapeutic agents.
Used in Medical Experimental Research:
In the field of medical research, ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate is utilized as a research tool to study the properties and interactions of carboxylic acid ester derivatives. This can help scientists better understand the mechanisms of action of related compounds and contribute to the advancement of medical knowledge and drug discovery.

Upstream product

• 105-56-6 ethyl 2-cyanoacetate 
• 49765-05-1 (Z) 3-amino-4,4,4-trichloro-2-cyano-2-butenoic acid ethyl ester 
• 22071-00-7 1-Amino-1-trichlormethyl-2-carbethoxy-2-cyano-ethylen 
• 121020-70-0 2-(cyanoethoxycarbonylmethylene)-1,3-dioxolane 

Downstream Products

• 82819-95-2 2-amino-3-ethoxycarbonyl-5-hydroxy-7-phenylpyrazolo<1,5-a>pyrimidine 
• 82819-89-4 3-phenylpropiolamido-4-ethoxycarbonyl-5-aminopyrazole 
• 74440-35-0 3,5-Diamino-1H-pyrazole-4-carboxylic acid hydrazide 

Relevant articles and documents

Alkyne derivative, preparation method and application thereof

The invention relates to an alkyne derivative and a preparation method thereof and application of the alkyne derivative in medicine, specifically to an alkyne derivative represented by general formula(I), a preparation method and a pharmaceutically accept

MACROCYCLE CONTAINING AMINOPYRAZOLE AND PYRIMIDINE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

The present application relates to a macrocycle containing aminopyrazole and pyrimidine, which is represented by formula (I), a pharmaceutical composition thereof, and a use thereof in inhibiting tropomyosin receptor kinase (Trk) activity and in treating diseases in mammals that are mediated by Trk.

AMINO PYRAZOLOPYRIMIDINE COMPOUND USED AS NEUROTROPHIC FACTOR TYROSINE KINASE RECEPTOR INHIBITOR

Provided is an amino pyrazolopyrimidine compound as represented by the following structural formula used as a neurotrophic factor tyrosine kinase receptor inhibitor. The compound can inhibit the activity of Trk kinase and can treat diseases mediated by a Trk tyrosine kinase receptor in mammals.